MétaCan
Menu
Back to cohort
Record W4295025149 · doi:10.1016/j.ygyno.2022.07.017

Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

2022· article· en· W4295025149 on OpenAlexaff
Willemijn L. van der Kolk, Ate G.J. van der Zee, Brian M. Slomovitz, Peter Baldwin, Helena C. van Doorn, Joanne A. de Hullu, Jacobus van der Velden, Katja N. Gaarenstroom, B.F.M. Slangen, Preben Kjølhede, Mats Brännström, Ignace Vergote, C M Holland, Robert L. Coleman, E.B.L. van Dorst, Willemien J. van Driel, David Nunns, Martin Widschwendter, David Nugent, Paul DiSilvestro, Robert S. Mannel, Ming Y. Tjiong, Dorry Boll, David Cibula, Al Covens, Diane Provencher, Ingo B. Runnebaum, Bradley J. Monk, Vanna Zanagnolo, Karl Tamussino, Maaike H.M. Oonk, Charles F. Levenback, Ralph H.M. Hermans, J Bouda, Aarti Sharma, David Luesley, Peter Ellis, Derek Cruickshank, Timothy J. Duncan, Katharina Kieser, Connie Palle, Nicola M. Spirtos, David M. O’Malley, Mario M. Leitão, Melissa A. Geller, K. K. Dhar, Viren Asher, Daniel H. Tobias, Christer Borgfeldt, Jayanthi Lea, Margareta Lood, Jo Bailey, Brynhildur Eyjólfsdóttir, Stephen Attard-Montalto, Krishnansu S. Tewari, P Persson, Ranjit Manchanda, Pernille Tine Jensen, Linda Van Le

Bibliographic record

VenueGynecologic Oncology · 2022
Typearticle
Languageen
FieldMedicine
TopicEndometrial and Cervical Cancer Treatments
Canadian institutionsUniversité de MontréalUniversity of Toronto
FundersKWF Kankerbestrijding
KeywordsMedicineSentinel lymph nodeVulvar cancerLymphadenectomyVulvar CarcinomaSentinel nodeStage (stratigraphy)SurgeryBasal cellLymph nodeVulvaInternal medicineCancer

Abstract

fetched live from OpenAlex

OBJECTIVE: Optimal management of the contralateral groin in patients with early-stage vulvar squamous cell carcinoma (VSCC) and a metastatic unilateral inguinal sentinel lymph node (SN) is unclear. We analyzed patients who participated in GROINSS-V I or II to determine whether treatment of the contralateral groin can safely be omitted in patients with a unilateral metastatic SN. METHODS: We selected the patients with a unilateral metastatic SN from the GROINSS-V I and II databases. We determined the incidence of contralateral additional non-SN metastases in patients with unilateral SN-metastasis who underwent bilateral inguinofemoral lymphadenectomy (IFL). In those who underwent only ipsilateral groin treatment or no further treatment, we determined the incidence of contralateral groin recurrences during follow-up. RESULTS: Of 1912 patients with early-stage VSCC, 366 had a unilateral metastatic SN. Subsequently, 244 had an IFL or no treatment of the contralateral groin. In seven patients (7/244; 2.9% [95% CI: 1.4%-5.8%]) disease was diagnosed in the contralateral groin: five had contralateral non-SN metastasis at IFL and two developed an isolated contralateral groin recurrence after no further treatment. Five of them had a primary tumor ≥30 mm. Bilateral radiotherapy was administered in 122 patients, of whom one (1/122; 0.8% [95% CI: 0.1%-4.5%]) had a contralateral groin recurrence. CONCLUSION: The risk of contralateral lymph node metastases in patients with early-stage VSCC and a unilateral metastatic SN is low. It appears safe to limit groin treatment to unilateral IFL or inguinofemoral radiotherapy in these cases.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.039
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.266
Teacher spread0.249 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations18
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueGynecologic OncologySame topicEndometrial and Cervical Cancer TreatmentsFrench-language works237,207